Kevin Stonewall's desire to find a cure started in 9th grade.
While most of his peers were focused on graduating and figuring out “what’s next?”, Kevin Stonewall was discovering colon cancer breakthroughs during his last year of the high school.
As a student working at a Rush University lab during his senior year, the teen from Chicago’s South Side (Ashburn neighborhood) found a critical age-related drawback in an experimental vaccine aimed at preventing colon cancer in mice, according to a report from DNAInfo.
The current rising sophomore and biomedical engineering major at the University of Wisconsin Madison continues to follow his love for science and research a colon cancer vaccine that can be tested on the elderly, and ultimately, be a cure.
“I am very passionate about doing colon cancer research,” Stonewall said. “If it works on humans, I would be overwhelmed. My whole life would flash in front of me.”
Stonewall’s lab director at Rush University, Carl Ruby, said that Stonewall’s experiment helped scientists realize that they needed a special vaccine for older subjects. Ruby said Stonewall, “should be heralded for helping to develop more effective colon cancer treatments that will impact the elderly, the population that is most susceptible to colon cancer.”
Ruby added, ““He has all the tools. He will go far.”
Stonewall’s first tools were four microscopes he received one Christmas from his parents when he was in the fifth grade.
His passion to cure colon cancer was ignited during his freshman year at the Chicago High School for Agricultural Sciences, after the uncle of one of his good friends was diagnosed with it and eventually died. “Cancer has taken over a whole bunch of lives, and I felt like I needed to step up and do something about it,” said Stonewall.
Read more about this amazing teen at BlackDoctor.Org.
BET Health News - We go beyond the music and entertainment world to bring you important medical information and health-related tips of special relevance to Blacks in the U.S. and around the world. Click here to subscribe to our newsletter.
(Photo: Courtesy INTEL via Vimeo)